The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Diabetic children treated with intensive insulin therapy are showing a dangerous increase in severe hypoglycemic episodes. The Continuous Glucose Monitoring System (CGMS) allows glycemic profiles to be monitored over a 72‐h period. The aim of the present study was to evaluate whether this system is sufficiently sensitive to detect asymptomatic hypoglycemia, and to determine if its periodic application would help to minimize the hypoglycemic risk in children with type 1 diabetes mellitus (T1DM). Methods: Twenty‐seven T1DM children (age range 6–13.1 years) were enrolled in the study. The sensor was inserted subcutaneously in each patient and the standard four or five registrations of capillary glycemia per day were performed. Eighteen patients continued in the study and the glucose sensor was again inserted after a 6‐week interval. At the beginning and end of the study, fructosamine, glycosylated hemoglobin (HbA 1c), median glycemia, number and duration of hypoglycemic events and insulin requirement were evaluated. Results: A significantly higher number of asymptomatic hypoglycemic events was revealed by CGMS in comparison with the standard system (3.6 ± 2.3 vs 0.7 ± 0.9; p < 0.0001). In patients who continued in the study, insulin therapy adjustments reduced the incidence of hypoglycemic events (2.5 ± 1.7 vs 3.9 ± 2.2; p < 0.05). At the 6‐week point, the fructosamine level was reduced (330 ± 30 vs 349 ± 24 µmol/l; p < 0.05). Conclusions: The CGMS is a useful device not only for detecting unrecognized hypoglycemia, but also for modifying insulin therapy in order to reduce hypoglycemic events. The system appears to be useful in avoiding long exposure to hypoglycemia. Copyright © 2002 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bode, B. W., Gross, T. M., Thornton, K. R., & Mastrototaro, J. J. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00113-8 · Cited by 232 · cited 1×
“A preliminary study has demonstrated that CGMS is helpful in adjusting insulin therapy: in adult diabetic patients who used CGMS periodically, a significant fall in glycosylated hemoglobin (HbA1c) values was observed after 5 and 10 weeks of monitoring with CGMS [13].”
BackgroundA Pilot Study of the Continuous Glucose Monitoring System
Kaufman, F. R., Gibson, L. C., Halvorson, M., Carpenter, S., Fisher, L. K., & Pitukcheewanont, P. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2030 · Cited by 224
Cited by
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Continuous glucose monitoring and closed‐loop systems
Hovorka, R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01672.x · Cited by 443
The Evidence for Medical Nutrition Therapy for Type 1 and Type 2 Diabetes in Adults
Franz, M. J., Powers, M. A., Leontos, C., Holzmeister, L. A., Kulkarni, K., Monk, A., Wedel, N., & Gradwell, E. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.09.014 · Cited by 306
Bailey, T. S., Zisser, H. C., & Garg, S. K. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0205 · Cited by 159
Glycemic Characteristics in Continuously Monitored Patients With Type 1 and Type 2 Diabetes
Bode, B. W., Schwartz, S., Stubbs, H. A., & Block, J. E. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2361 · Cited by 137
Metadata
- Authors
- Schiaffini, R., Ciampalini, P., Fierabracci, A., Spera, S., Borrelli, P., Bottazzo, G. F., & Crinò, A.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 18
- Issue
- 4
- Pages
- 324-329
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2084202677
- Cited by
- 77
- References
- 2
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. https://app.cochat.ai/papers/10.1002/dmrr.309
- The paper
- Schiaffini, R., Ciampalini, P., Fierabracci, A., Spera, S., Borrelli, P., Bottazzo, G. F., & Crinò, A. (2002). The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.309
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.